Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 07  •  04:00PM ET
34.38
Dollar change
-0.37
Percentage change
-1.06
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y11.20% Total Holdings68 Perf Week-2.46%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y4.57% AUM20.63M Perf Month4.48%
Fund Family Bond Type Tagshealthcare Return% 5Y-0.56% NAV/sh Perf Quarter22.74%
Index- Average Maturity Tagsgenomics Return% 10Y 52W High35.25 -2.46% Perf Half Y25.08%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.74 44.84% Perf YTD19.19%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.36% 0.43% Perf Year11.11%
Dividend TTM- ESG Type Tags- Flows% 3M17.97% ATR (14)0.41 Perf 3Y12.30%
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD27.24% RSI (14)59.05 Perf 5Y-7.43%
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.06 Perf 10Y-
Expense0.50% Growth/Value SMA200.96% Flows% 3Y Rel Volume0.03 Prev Close34.76
Inverse/Leveraged Market Cap SMA506.75% Flows% 5Y Avg Volume4.33K Price34.38
IPOFeb 27, 2020 Option/ShortYes / Yes SMA20018.46% Trades Volume135 Change-1.06%
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-20-25 11:28AM
Apr-18-25 01:40PM
08:30AM Loading…
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.